1. Home
  2. TARS vs AMPL Comparison

TARS vs AMPL Comparison

Compare TARS & AMPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • AMPL
  • Stock Information
  • Founded
  • TARS 2016
  • AMPL 2012
  • Country
  • TARS United States
  • AMPL United States
  • Employees
  • TARS N/A
  • AMPL N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • AMPL EDP Services
  • Sector
  • TARS Health Care
  • AMPL Technology
  • Exchange
  • TARS Nasdaq
  • AMPL Nasdaq
  • Market Cap
  • TARS 1.7B
  • AMPL 1.7B
  • IPO Year
  • TARS 2020
  • AMPL 2021
  • Fundamental
  • Price
  • TARS $51.69
  • AMPL $11.45
  • Analyst Decision
  • TARS Strong Buy
  • AMPL Buy
  • Analyst Count
  • TARS 7
  • AMPL 10
  • Target Price
  • TARS $67.14
  • AMPL $13.70
  • AVG Volume (30 Days)
  • TARS 679.4K
  • AMPL 1.8M
  • Earning Date
  • TARS 11-12-2025
  • AMPL 11-06-2025
  • Dividend Yield
  • TARS N/A
  • AMPL N/A
  • EPS Growth
  • TARS N/A
  • AMPL N/A
  • EPS
  • TARS N/A
  • AMPL N/A
  • Revenue
  • TARS $295,521,000.00
  • AMPL $316,571,000.00
  • Revenue This Year
  • TARS $33,170.29
  • AMPL $15.04
  • Revenue Next Year
  • TARS N/A
  • AMPL $12.65
  • P/E Ratio
  • TARS N/A
  • AMPL N/A
  • Revenue Growth
  • TARS 254.45
  • AMPL 9.93
  • 52 Week Low
  • TARS $30.23
  • AMPL $7.55
  • 52 Week High
  • TARS $59.76
  • AMPL $14.88
  • Technical
  • Relative Strength Index (RSI)
  • TARS 46.25
  • AMPL 51.00
  • Support Level
  • TARS $48.20
  • AMPL $10.67
  • Resistance Level
  • TARS $59.76
  • AMPL $11.59
  • Average True Range (ATR)
  • TARS 2.04
  • AMPL 0.47
  • MACD
  • TARS -1.29
  • AMPL 0.04
  • Stochastic Oscillator
  • TARS 30.19
  • AMPL 60.94

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue primarily through selling subscriptions to the platform. The company derives a majority of its revenue from the United States.

Share on Social Networks: